14.50MMarket Cap-362P/E (TTM)
0.5480High0.4860Low3.42KVolume0.5480Open0.5194Pre Close1.72KTurnover0.03%Turnover RatioLossP/E (Static)29.00MShares1.530052wk High-0.53P/B5.89MFloat Cap0.340052wk Low--Dividend TTM11.78MShs Float28.7109Historical High--Div YieldTTM11.94%Amplitude0.3400Historical Low0.5030Avg Price1Lot Size
Centogene Stock Forum
Centogene And C-Path Sign MOU For Collaboration In Lysosomal Disease Research And Drug Development
Zzzz 😴😴
NEWS (LATE)
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
Centogene (Nasdaq: CNTG) has secured approximately $20 million in funding through an expanded relationship with Lifera, a biopharma company owned by Saudi Arabia's Public Investment Fund (PIF). This includes a $15 million purchase of Centogene’s accounts receivables and additional investments in their joint venture. The financing bolsters Centogene’s liquidity, supporting operations and strategic i...
NEWS
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
CENTOGENE and Evotec announced the discovery of a promising new molecule with potential to treat type 2 and type 3 Gaucher disease. The discovery stems from their ongoing drug discovery partnership initiated in 2020, now extended for another year. Evotec has received an R&D license for continued development and has an exclusive option until March 31, 2025, to license CENTOGENE’s share of the...
No comment yet